
Soranib Tablet - Advanced Formulation, Targeted Cancer Treatment | Improved Bioavailability, Enhanced Efficacy, Convenient Dosage
Price:
Get Latest Price
In Stock
Product Specifications
| Salt Composition | Sorafenib 200 mg |
| Dosage Form | Tablet |
| Indication | Used for the treatment of advanced renal cell carcinoma and hepatocellular carcinoma |
| Ingredients | Active ingredient: Sorafenib Tosylate; Excipients: as per formulation |
| Application | Anticancer medication |
| Physical Color/Texture | Light yellow, capsule-shaped tablets |
| Storage Instructions | Store below 25A C, protect from moisture |
| Shelf Life | 24 months from manufacture |
| Feature | Oral multi-kinase inhibitor for targeted cancer therapy |
| Delivery Time | 1 Week |
| Supply Ability | 30 Per Day |
| Main Domestic Market | All India |
| Main Export Market(s) | Western Europe |
| Sample Available | 1 |
| GSTIN | 0% |
Company Details
Business Type
Exporter, Distributor, Trading Company
Employee Count
10
Establishment
1991
Working Days
Monday To Sunday
GST NO
27AARFP5752B1Z1
Related Products
Explore Related Categories
More Products From This Seller
Seller Details
GST - 27AARFP5752B1Z1
Mumbai, Maharashtra
Proprietor
Mr Amith Dhiraj Galaa
Address
12/B, Thacker Industrial Estate, N. M. Joshi Marg, Lower Parel (E), Mumbai, Maharashtra, 400011, India
anti cancer medicine in Mumbai
Report incorrect details










































